We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
-13.46%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$627M
AUM Growth
-$205M
Cap. Flow
-$88.2M
Cap. Flow %
-14.06%
Top 10 Hldgs %
25.67%
Holding
102
New
6
Increased
38
Reduced
34
Closed
11

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$15.4M
2
HUM icon
Humana
HUM
+$14.8M
3
PFE icon
Pfizer
PFE
+$14.2M
4
MCK icon
McKesson
MCK
+$11M
5
AMGN icon
Amgen
AMGN
+$10.4M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$20.3M
2
JNJ icon
Johnson & Johnson
JNJ
+$18.6M
3
UNH icon
UnitedHealth
UNH
+$10.1M
4
RAD
Rite Aid Corporation
RAD
+$9.6M
5
CVS icon
CVS Health
CVS
+$9.15M

Sector Composition

Rank Sector Weight
1 Healthcare 91.99%
2 Financials 2.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THOR
101
DELISTED
THORATEC CORPORATION
THOR
– –
-110,000
Closed -$4.9M
RCPT
102
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
– –
-28,000
Closed -$5.32M
1 2 3 4
5

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
CL
CVFG LLC Shelbyville, Indiana $804M AUM 27.61% 1-Year Est. Return

Rhenman & Partners Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, Rhenman & Partners Asset Management held 102 positions worth $627M, down 25% from $833M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rhenman & Partners Asset Management withdrew a net $88.2M in Q3 2015, closing 11 positions and reducing 34 holdings. Its most notable exit was Biogen, an estimated $20.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 77% a quarter earlier, followed by Financials.

Against the trend, Rhenman & Partners Asset Management opened a new position in Cigna worth $14.3M.

  • Rhenman & Partners Asset Management's largest Q3 2015 buy was Cigna: 105,900 shares worth $14.3M.
  • Rhenman & Partners Asset Management added most to McKesson in Q3 2015, an estimated $11M increase.
  • Rhenman & Partners Asset Management's biggest Q3 2015 reduction was UnitedHealth, cutting an estimated $10.1M.
  • Rhenman & Partners Asset Management fully exited Biogen in Q3 2015, selling an estimated $20.3M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 26% of its $627M portfolio in Q3 2015.
  • Rhenman & Partners Asset Management opened 6 new positions and closed 11 in Q3 2015.
  • Rhenman & Partners Asset Management's portfolio value fell 25% quarter-over-quarter to $627M.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2015, filed 26 Oct 2015.